Hypertension Clinical Trials

Find Hypertension Clinical Trials Near You

Accuracy of a Cuffless Photoplethysmography (PPG) Chest-Patch Monitor for 24-hour Ambulatory Blood Pressure Monitoring

Status: Recruiting
Location: See all (10) locations...
Intervention Type: Device
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

This study aims to validate the accuracy and reliability of blood pressure (BP) estimates obtained over 24 hours using a PPG-based chest-patch device compared to the gold standard ambulatory blood pressure monitoring (ABPM) method using an upper arm cuff-based oscillometric BP device, in both hypertensive and normotensive individuals referred by their provider to undergo a 24-hours ABPM for clinical indication. The Awake/Asleep test, which is the primary test recommended for automated wearable cuffless BP devices that are cuff-calibrated (based on the 2023 European Society of Hypertension (ESH) recommendations for the validation of cuffless blood pressure measuring devices), will be conducted in this study. The secondary aim of the study is to assess the feasibility and convenience of the PPG-based device.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:

• Females and Males subjects 18 years or older (from all skin tones/colors)

• Scheduled for ABPM for hypertension screening, evaluation, or management

• Subjects capable of using an application temporarily downloaded (for the duration of the study) on a personal smart phone device or on a device provided by the study sponsor

• Subjects with Atrial fibrillation or Atrial flutter are eligible to participate if standard cuff-based ABPM monitor can capture blood pressure at initialization

Locations
United States
Alabama
Cardiology, P.C.
RECRUITING
Birmingham
Arizona
Mayo Clinic
RECRUITING
Scottsdale
Florida
Mayo Clinic
RECRUITING
Jacksonville
U Health-University of Miami Health System
RECRUITING
Miami
Minnesota
Mayo Clinic
RECRUITING
Rochester
Other Locations
Israel
HaEmek Hospital
RECRUITING
Afula
The Holy Family Hospital Nazareth
RECRUITING
Nazareth
Sheba Medical Center
RECRUITING
Ramat Gan
Maccabi Healthcare
RECRUITING
Tel Aviv
Italy
Instituto Auxologico Italiano
NOT_YET_RECRUITING
Milan
Contact Information
Primary
Ruth Caspi-Molad, M.S.c
ruthie.caspi@bio-beat.com
+972546969474
Time Frame
Start Date: 2025-12-15
Estimated Completion Date: 2026-10-30
Participants
Target number of participants: 600
Treatments
Experimental: Device: Non-invasive monitoring
The study is designed as a prospective, multicenter, single arm, validation study that follows the 2023 European Society of Hypertension (ESH) recommendations for the validation of cuffless blood pressure measuring devices.27 There is no primary hypothesis. The study will validate 24-hours blood pressure monitoring using the investigational FDA-cleared device by comparing the level of agreement with parallel measurements obtained by the gold-standard upper arm. The Awake/Asleep test is the first and primary test recommended for this type of device to assess validity.
Related Therapeutic Areas
Sponsors
Collaborators: Mayo Clinic
Leads: Biobeat Technologies Ltd.

This content was sourced from clinicaltrials.gov